The usual cause for the fund is to invest in rounds with 6 partakers. Despite the aMoon2 Fund, startups are often financed by Pontifax, OrbiMed, Novartis Venture Fund. The meaningful sponsors for the fund in investment in the same round are Samsung Ventures, Pontifax, OrbiMed.
Among the most successful fund investment fields, there are Medical, Health Care. Among the various public portfolio startups of the fund, we may underline Adicet Bio Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.
The fund is generally included in less than 2 deals every year. Deals in the range of 50 - 100 millions dollars are the general things for fund. The high activity for fund was in 2019.
| Fund Name | Location |
| Abstraction Capital | Kansas City, Missouri, United States |
| Arab Palestinian Investment Company (APIC) | - |
| Ascendis Pharma | California, Palo Alto, United States |
| Black Beret Life Sciences | Houston, Texas, United States |
| CMG-SDIC Capital Management | Beijing, Beijing, China |
| DoubleRock | California, Menlo Park, United States |
| ES Investor | Seoul, Seoul-t'ukpyolsi, South Korea |
| Kyocera Corporation | Japan, Kyoto, Kyoto Prefecture |
| Manna Tree | Colorado, United States, Vail |
| NFX Ventures | - |
| Paysmark Verwaltungs- und Beteiligungsgesellschaft mbH | - |
| Roclink Capital | Canada, Ontario, Toronto |
| Smart Sparks Angel Network | Calicut, India, Kerala |
| Sony Electronics | California, San Diego, United States |
| Summer Wind Capital | New York, New York, United States |
| Venture Frogs | California, San Francisco, United States |
| Women's World Banking | New York, New York, United States |
| Zon Capital Partners | New Jersey, Princeton, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Adicet Bio | $80M | 02 Sep 2019 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Adicet Bio | $80M | 02 Sep 2019 | California, United States |
